<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Immunocompromised children, including those undergoing chemotherapy treatment of malignant disease, are at particular risk for <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> with parvovirus B19 </plain></SENT>
<SENT sid="1" pm="."><plain>However, these patients' attenuated immune responses may obscure the serologic and clinical manifestations of the <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>The authors describe a patient undergoing induction therapy for <z:hpo ids='HP_0006721'>acute lymphoblastic leukemia</z:hpo> whose <z:e sem="disease" ids="C0085273" disease_type="Disease or Syndrome" abbrv="">parvovirus B19 infection</z:e> was identified by the incidental detection of giant pronormoblasts and absence of <z:mpath ids='MPATH_458'>normal</z:mpath> mature erythroid precursors, characteristic of <z:e sem="disease" ids="C0205882" disease_type="Disease or Syndrome" abbrv="">parvovirus infection</z:e>, on a routine bone marrow examination </plain></SENT>
<SENT sid="3" pm="."><plain>Intravenous immunoglobulin was administered and the patient's <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> resolved completely within 3 weeks </plain></SENT>
<SENT sid="4" pm="."><plain>This highlights the importance of alertness to the possibility of <z:e sem="disease" ids="C0205882" disease_type="Disease or Syndrome" abbrv="">parvovirus infection</z:e> in children with <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> </plain></SENT>
</text></document>